Browse the published research from 23andMe, and you may be amazed by how much the genetic testing startup has discovered in a few years.
Send in your spit and take a few surveys, and you’ll get an idea of how much more is coming.
Since launching in 2006, 23andMe has collected and analyzed DNA samples from 1.2-million customers, with the majority allowing their data to be used in research. Although facing controversy over (past) FDA concerns, (current) partnerships with pharmaceutical companies, and (future) plans to develop its own drugs, the billion-dollar company has always said its mission is to help people access, understand, and benefit from the human genome. There’s no doubt it has made contributions there.
